Clearwater Paper Reports Third Quarter 2023 Results
*Outstanding performance driven by strong operational results and continued market strength in tissue *Net sales of $520 million, down 3% from the third quarter of last year *Net income of $37 million, or $2.17 per diluted share *Redeeming 2025 notes in Q4 2023 with a combination of a new term loan, cash on hand, and drawing on existing ABL facility *Repurchased $5 million of outstanding shares, with $10 million remaining under program *Reduced net debt by $69 million from second quarter of this year, $416 million since 2020